Study on the Relationship of Plasminogen Activator Inhibitor type 1 and Ultrasensitive C-reative Protein in Patient with Metabolic Syndrome and Coronary Heart Disease.
- VernacularTitle:PAI-1和超敏CRP与代谢综合征合并冠心病关系的研究
- Author:
Wenzhen YAN
;
Shutian HUANG
;
Ruiying WANG
- Publication Type:Journal Article
- Keywords:
Metabolic syndrome;
Plasminogen activator inhibitor type 1;
Ultrasensitive C-reative protein;
Coronary heart disease
- From:
Journal of Medical Research
2006;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relationship of plasminogen activator inhibitor type 1(PAI-1) and ultrasensitive C-reative protein(hsCRP) in patient with metabolic syndrome and coronary heart disease.Methods Between June 2006 and December 2007,87 patients with metabolic syndrome were divded into two groups:simple MS group which consisted of 45 patients and MS with CHD group which consisted of 42 patients.30 health people at the same stage,whose age and sex were similar with those in MS group served as normal control group.The levels of body mass index(BMI),waist circumference(WC),systolic blood presser(SBP),diastolic blood presser(DBP),triglyceride(TG),total cholesterol(TC),high density lipoprotein cholesterol(HDL-C),fasting plasma glucose(FPG),PAI-1 and hsCRP were measared.Results BMI,WC,FPG,SBP,DBP,TG,PAI-1 and hsCRP in both MS groups were higher than those in normal control group(P
